Dermata Therapeutics(DRMA) - 2025 Q4 - Annual Results

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 - Dermata announced a strategic pivot to develop and commercialize direct-to-consumer ("DTC") skincare products under the brand name Tome - - Dermata plans to launch its first DTC product, our Foundational Treatment, a once-weekly mask to support a skin renewal, in the middle of 2026 - - Raised $4.125 million in gross proceeds from a private placement financing in December 2025, including participation from ...